
|Articles|April 1, 2003
Price Tag Holds Back Biologics for Psoriasis
The use of biologics to treat psoriasis is on the move. A couple of systemic medications have received FDA approval for psoriasis and related conditions, and several more are in the pipeline. Although the drugs are reputed to cause fewer and less serious side effects than traditional psoriasis treatments, that doesn't mean side effects don't exist, and that makes them an issue for some doctors and patients alike.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements
2
Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference
3
Treatment Plan Expectations and Previewing the 2026 Pipeline
4
Is It Just a Rash? Key Issues in Diagnosing and Treating Cutaneous Lupus
5



















